Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06559774 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Hastiin Bidziil (Strong Man) Intervention

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria shortened, about 1 wordv14
  2. Primary completion pushed from Mar 2027 to Jun 2027
    • Study completion moved earlier from Mar 2029 to Jun 2028
    v13
  3. Eligibility criteria expanded, about 2 wordsv12
  4. Re-verified, no change to tracked fieldsv11
  5. Start date: May 2, 2025 to Jun 18, 2025v10
Show 8 earlier versionsHide 8 earlier versions
  1. Re-verified, no change to tracked fieldsv9
  2. Start date: Apr 14, 2025 to May 2, 2025v8
  3. Start date: Mar 25, 2025 to Apr 14, 2025v7
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 2025 to Mar 25, 2025
    • Site details revised at 2 of 2 sites
    v6
  5. Primary completion date: Jan 2027 to Mar 2027
    • Study completion date: Jan 2029 to Mar 2029
    • Start date: Jan 2025 to Mar 2025
    v5
  6. Primary completion date: Dec 2026 to Jan 2027
    • Study completion date: Dec 2028 to Jan 2029
    • Start date: Dec 2024 to Jan 2025
    v4
  7. Start date: Oct 2024 to Dec 2024
    • Primary completion date: Oct 2026 to Dec 2026
    • Study completion date: Oct 2028 to Dec 2028
    v3
  8. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The Hastiin Bidziil (Strong man) Intervention study is part of a larger project called, Community-Driven Indigenous Research, Cultural Strengths \& Leadership to Advance Equity in Substance Use Outcomes (CIRCLE) Center of Excellence. CIRCLE aims to address drug use related health problems in collaboration with diverse Indigenous communities. This study is a randomized controlled trial study to measure the effectiveness of a secondary prevention program, called Hastiin Bidziil (Strong Man), aimed at reducing substance use among Native American Indian (AI) men ages 18 years and older
Trial Details
NCT Number NCT06559774
Lead Sponsor Johns Hopkins Bloomberg School of Public Health
Conditions
(from sponsor)		 Substance Use
Related terms Substance-Related Disorders
Enrollment 160 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov